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Stereotactic radiosurgery (SRS) is perfornled with increasing frequency in the treatment of residual or recurrent 
pituitmy' adenomas. Its major associated risk in these cases of residual or reClUTent pituitary tlUnor adjacent to nonnaI 
functional pituitary gland is radiation exposure to the pituitary, which frequently leads to the development of hypo pi-
tuitari:::'1ll. TIle authors describe a technique or pituitary transposition to reduce the radiation dose to Ule nonnal pitu-
itary gland in cases of planned radiosurgical treatment of residual pituitaI): adenoma \\'ithin the cavernous sinus. A sel-
lar exploration for tumor resection is perfonned, the pituitalJ! gland is transposed from the region of the cavernous 
sinus, and [l fat and fascia grail:: is interposed benyeen the nomwl pituitmy gland mId the residUEll tlUnor in the ca\'-
emous sinus. The residual tumor may then be treated \vith SRS. ·llle increased distance benveen the nonnal pituitary 
glmld <.Uld Ule residual tlunOf lacilitates lrcaunl,.'nt OrUle tLUnor WiUl radiosurgl,.'fY and [( .. 'duces radiation exposure to Ule 
nonnal pituitary gland. 
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The most significant complication fo11owing conven-
tional radiotherapy for residual or recurrent pituitary 
tumors is hypopituitarism, which requires life-long hor-
mone replacement thcrapy.I-3,7.17,2'I,:~ Radiation-induced 
hypopituitarism is thought to result from direct damage to 
the pituitary gland and secondary damage to the hypothal-
amus. Up to 50% of patients with nonnal pituitary func-
tions develop hypopituitarism within 5 to 20 years after 
undergoing conventional radiotherapy.lR,n The time of 
onset is dose dependent, and its incidence increases with 
time from exposure. 19 Therefore,long-tenn follow-up stu-
d:y in these paticnts is necessary. 
Radiosurgery has the potential to deliver high doses of 
radiation to the target lesion while reducing the dose to the 
surrounding nonnal structurcs. TI1e proximity of the gland 
to the region of treatment, however, may carry the risk of 
developing hypopituitarism, even when SRS is applied. 
Stereotactic radiosurgery is being used more frequently 
in the treatment of pituitary tumors, both functioning and 
nonfullctioning, for residual tumor within the cavernous 
sinus.l0-12.14,15,22.25.26,29 The preliminary data regarding tu-
Abbreviations used in Ihis paper: ACTll = adrenocorticotropic 
honnone; Ci\ = carotid arkry; 1v1R = magnetic resonm1ce; SRS = 
stereotactic radiosurgery. 
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cavernous sinus hypopituitarism 
mor control and nonnalization of hyperseeretory syn-
dromes after SRS appear promising. 2,') 17)1,2:,2\21'i,::::9)O 
In cases in which there is cavenlOUS sinus invasion and 
residual tumor is expected, tl,e senior author (W.T.c.) has 
developed a technique for pituitary transposition ("hypo-
physopexy") in anticipation of postoperative radiosurgieal 
treatment. This teclmique involves transposing the normal 
pituitary gland mvay from the eavenlOUS sinus tumor and 
interposing a fat graft between the nonnal gland and the 
tumor in the cavernous sinus. This increases the distmlce 
between the normal pituitary gland and residual tumor to 
facilitate SRS treatment of the tumor, thereby reducing the 
effective biological dose to the nomlal pituitary gland. 
This reduction decreases the likelihood that hypopituitar-
ism will develop. Although tl,is technique has been de-
scribed in the pituitary literature,' we detail it here for the 
neurosurgical readership and provide illustrative cases. 
CLINICAL MATERIAL AND METHODS 
Pituitary 1'ran.\po.\·ition 
A standard trans sphenoidal approach (usually llllilateral 
endonasal) is initially perfonned. Via an extended trans-
sphenoidal approach, thc osseous removal is then extend-
ed laterally toward the side of the eavemous sinus that in-
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volves tumor. 6.20 Maximum tmnor resection is performed 
while leaving residual tumor in the cavenlOUS sinus. Au-
tologous fat and fascia lata are harvested from the pa-
tient's thigh in preparation for the pituitary transposition. 
The nonnal pituitary gland is usually casily dissceted 
trom the adjacent recurrent hunor and displaced laterally 
mvay from the involved cavenlOUS sinus. In addition, a 
margin of nonllal gland is removed trom the hUlIor inter-
face to ensure that none of the lesion is adherent to the 
nonnal gland berore transposition. Fat is then interposed 
between the gland mld the involved cavernous sinus to 
maintain the transposition. TI1C closure then proceeds in a 
standard fashion. with fascia lata placed over the dural 
opcning and additional rat gran within thc sphcnoid sinus 
to buttress the fascia. 
Wc nonnally usc autologous rat and raseia as gran ma-
terial to prevent formation of cerebrospinal fluid fishl-
las. \6)0 The graft in these instances is contiguous with the 
standard rat-rascial gran placed in thc sclla and sphenoid 
sinus. Necrosis and shrinkage of the graft ane expected in 
time and aner radiosurgical trcatment; this factor must be 
considered when ulldertakillg tractionated treatments. If 
longer time periods for delivery of fractionated doses ane 
considered, other more penn anent materials, such as bone 
substitutes, may be better suited to maintain transposition 
or the gland. 
CASE ILLUSTRATIONS 
Case 1 
History. This 16-year-old woman with acromegaly. 
treated at another institution. initially undenvent an un-
complicated resection of her pihlitarY macroadenoma via 
a trans sphenoidal route. A subtotal resection was per-
fonned, ""vith residual tumor remaining in the len cav-
emous sinus. The patient remained clinically stable for 
more than 3 years ,vhi1c attending regular follow-up vis-
its. She then noted some recurrence of the soft-tissue 
changes that she had experienced initially. The insulin-
like growth raetor-T level had continuously and rapidly 
elevated from 151 to 387 ng/ml over a 5-month period. 
and her serum growth honnonc level had increased to 39 
ng/ml. A repeated MR imaging shldy of the pihlitary re-
vealed residual tumor centered in the left cavenlOUS sinus 
mld in the enlarged sella just medial to it. Because of her 
recurrent progressive endocrinopathy and enlarging tu-
mor, treatment ,\/as recommcnded. She refused medical 
treatment with a somatostatin mlalog; therefore. surgical 
removal and/or radio surgical treatment of the remaining 
hUlIor was plmllled. The patient was yOlUlg mld lllUlIar-
ried; she was adamant about hcr dcsire that any planned 
treatment not afteet her fertility. 
Operation. A decision was made to reexplore the sella 
and parasellar region. The goals of surgery were maxi-
mum tumor resection and movement of the normal pitu-
itary glmld away from the residual tumor io preparation 
ror radiosurgery. A standard microsurgical sub labial trans-
sphenoidal approach was initially perfonlled. as previous-
ly described.' Via an cxtendcd transsphenoidal route, 
additional bone was removed laterally to expose the hUlIor 
in the left lateral sella and eavemous sinus.20 The nonnal 
pituitary gland was easily discemible rrom the residual 
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pihlitary adenoma. The hUlIor was dissected trom the 
gland, and a 2-mm margin of nonnal lateral gland was 
removed to ensure its completc excision from the gland 
itself. The hUlIor was fibrous mld ditlicult to dissect from 
the dura and CA. Aner cxtirpation or thc medial aspcet or 
the hUlIor. we decided to leave the remaining tumor in the 
cavenlOUS sinus and to treat it radiosurgically to avoid the 
risk of CA injury and cavemous cranial neuropathy. A fat 
and fascia lata graft was harvested from the lateral thigh. 
The pituitary gland was thcn displaced to the right, and 
a fat graft was inserted to hold the gland away from the 
residual tumor and eavemous sinus (Fig. I). Fascia lata 
and a fat graft were then placed over the dural opening to 
prevcnt ronnation or a cerebrospinal nuid fistula. 
PostoperatiYe Course and SRS. The postoperatiYe 
course ,vas uneventful, and the patient ,·vas discharged to 
home on the 3rd postoperative day. On postoperative Day 
14 thc residual tumor was treatcd with SRS without com-
plication. Two IO-Gy fractions were delivered 4 weeks 
apart by using the Novalis shaped-bemn system. Minimul-
tileaf collimators were used to conform the treatment to 
the tumor while maintaining the dose to the brainstem and 
optic apparatus outside the 60% isodosc rcgion (Fig. I). 
TrmlSposition of the pihlitary glmld laterally with the fat 
grart cnabled the radiation dose to thc gland to be kept 
below the 50% isodose. At the time of her second treat-
ment' some necrosis and retraction of the fat graft were 
already visible. Both treatmcnts \vere uneventful. Ten 
montIls after SRS, her groWtIl honnone and insulin-like 
growth raetor-T levels had deereascd to 2.1 ng/ml and 181 
ng/ml. respectively. One year postoperatively. nonllallev-
els of otI,er adenohypophysial honnones persisted (pro-
lactin. 16 ng/ml) mld her usual menstrual periods occurred 
approximately every 30 days. Extemal ocular movements 
and facial sensation remain intact. 
Case 2 
History. This 42-year-old woman presented with 
Cushing disease secondary to an ACTH-secreting pitu-
itarv tumor that extended into tI,e left cavernous sinus 
ene'asing tI,e CA. Her ACTH level preoperatively was 93 
pg/ml. A transsphcnoidal rcsection was pcrronncd, and 
residual tumor, which invaded the left eavemous sinus, 
was len in place (Fig. 2). Postopcratively, elevated ACTH 
levels of 53 pg/ml persisted. mld she suffered frommalig-
nant endocrinopathy. She was referred to an endocrinolo-
gist for adjuvmlt therapy; however. her follow-up stahlS 
was suboptimal. A repeated MR imaging study I year 
later revealed recurrent tumor cxtending into the suprasel-
lar cistern with radiographically demonstrated stable dis-
ease within the cavenlOUS sinus. 
Operation. Because of her pcrsistent endocrinopathy 
(ACTH level 59 pg/ml mld elevated 24-hour urine free 
cortisol) and recurrent hun or, we decided to reexplore the 
sella and parasellar regions. remove all accessible hUll or. 
and transpose the pihlitary glmld in preparation for radio-
surgical treatment of the cavemous sinus tumor. An endo-
nasal trmlssphenoidal approach was used. Bone was re-
movcd laterally to expose thc tumor in the Iert latcral sella 
mld cavernous sinus. A plmle was defined between the 
nonnal gland and tI,e tumor. Mter removing the medial 
aspect or thc tumor adjacent to thc nonnal gland, a rat 
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